Retinal Disorders – Therapy Market Snapshot

ReportsWorldwide has announced the addition of a new report title Retinal Disorders – Therapy Market Snapshot to its growing collection of premium market research reports.
By: ReportsWorldwide
BOSTON - Nov. 22, 2017 - PRLog -- A range of disorders, some of which share similar underlying pathologies, can affect the retina and lead to progressively worsening vision and eventual blindness. The retina is the layer of light-sensitive tissue at the back of the eye that converts light into impulses to the brain via the optic nerve. A common feature of certain retinal disorders is abnormal growth of blood vessels in the macula, which can be effectively treated by drugs targeting vascular endothelial growth factor. These discrete indications are wet age-related macular degeneration, diabetic retinopathy with and without diabetic macular edema, and macular edema from retinal vein occlusion.

The report of 142 pages, 40 tables and 35 figures covers the below topics in detail:

• Treatment
• Marketed Drugs –Profiles of Avastin, Eylea, Lucentis and Ozurdex
• Drug Pipeline – Late stage product profiles of Zuprata, abicipar pegol, brolucizumab and squalamine

For a Detailed description and table of contents of this Datamonitor Healthcare report please click here:

Below is a Snapshot of Retina Disorders therapy market :

• New therapies will sustain market growth beyond expiries for first-generation anti-VEGF injections.
• Anti-VEGFs lead treatment dynamics, although choice of specific therapy is widely variable between countries.
• Common retinal disorders will contribute to over four million cases in 2016; this is expected to rise in the future.
• Eylea has become the clinical gold standard and market-leading anti-VEGF therapy.
• Brolucizumab's Phase III data position it as a direct competitor to the $5bn VEGF inhibitor Eylea.

To Get Sample Copy of Report please visit @

About is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Abigail Crasto
Senior Vice President
Posted By:*** Email Verified
Tags:Retinal Disorder, Market
Location:Boston - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse News
Most Viewed
Daily News

Like PRLog?
Click to Share